Augmentation of Stimulator of Interferon Genes–Induced Type I Interferon Production in COPA Syndrome.

Kato, Takashi; Yamamoto, Masaki; Honda, Yoshitaka; Orimo, Takashi; Sasaki, Izumi; Murakami, Kohei; Hemmi, Hiroaki; Fukuda‐Ohta, Yuri; Isono, Kyoichi; Takayama, Saki; Nakamura, Hidenori; Otsuki, Yoshiro; Miyamoto, Toshiaki; Takita, Junko; Yasumi, Takahiro; Nishikomori, Ryuta; Matsubayashi, Tadashi; Izawa, Kazushi; Kaisho, Tsuneyasu

Objective: Coatomer subunit alpha (COPA) syndrome, also known as autoinflammatory interstitial lung, joint, and kidney disease, is caused by heterozygous mutations in COPA. We identified a novel COPA variant in 4 patients in one family. We undertook this study to elucidate whether and how the variant causes manifestations of COPA syndrome by studying these 4 patients and by analyzing results from a gene‐targeted mouse model. Methods: We performed whole‐exome sequencing in 7 family members and measured the type I interferon (IFN) signature of the peripheral blood cells. We analyzed the effects of COPA variants in in vitro experiments and in Copa mutant mice that were generated. Results: We identified a heterozygous variant of COPA (c.725T>G, p.Val242Gly) in the 4 affected members of the family. The IFN score was high in the members carrying the variant. In vitro analysis revealed that COPA V242G, as well as the previously reported disease‐causing variants, augmented stimulator of interferon genes (STING)–induced type I IFN promoter activities. CopaV242G/ mice manifested interstitial lung disease and STING‐dependent elevation of IFN‐stimulated gene expression. In CopaV242G/ dendritic cells, the STING pathway was not constitutively activated but was hyperactivated upon stimulation, leading to increased type I IFN production. Conclusion: V242G, a novel COPA variant, was found in 4 patients from one family. In gene‐targeted mice with the V242G variant, interstitial lung disease was recapitulated and augmented responses of the STING pathway, leading to an increase in type I IFN production, were demonstrated.

IN vitro studies; GENETIC mutation; GENETICS; JOINT diseases; ANIMAL experimentation; INTERSTITIAL lung diseases; PERIPHERAL nervous system; INTERFERONS; KIDNEY diseases; GENE expression; GENOMES; DESCRIPTIVE statistics; MICE

Arthritis & Rheumatology, 2021, Vol 73, Issue 11, p2105

2326-5191

Academic Journal

10.1002/art.41790